Completed NA INTERVENTIONAL 2-arm NCT01544309

LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts (LISTEN)

Study on Effect of Highly Potent Statins on Lipid Lowering Effect and Glucose Metabolism in Hypercholesterolemia Patients With Diabetes Mellitus

Sponsor: Listen Trial Group

Conditions Hypercholesterolemia With Concomitant Type 2 Diabetes

Interventions Atorvastatin Rosuvastatin

Updated 6 times since 2017 Last updated: Mar 4, 2015 Started: Mar 31, 2012 Primary completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01544309, this NA trial focuses on Hypercholesterolemia With Concomitant Type 2 Diabetes and remains completed. Sponsored by Listen Trial Group, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Listen Trial Group

Data source: Listen Trial Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ageo, Japan , Amagasaki, Japan , Anan, Japan , Awa, Japan , Ayase, Japan , Chigasaki, Japan , Chuo Ku, Japan , Fujiidera, Japan , Fukui, Japan , Fukuoka, Japan and 77 more locations